Takeda business partner Foundation Care is making 340B covered entities declare on a form whether they will opt in or opt out of 340B pricing “on eligible product purchases,” as a condition for obtaining a Takeda leukemia drug | Shutterstock
Takeda Pharmacy Partner Forcing 340B Pricing Opt-in/Opt-out Choice on Entities
Drug manufacturer Takeda’s designated specialty pharmacy and distributor for its leukemia drug Iclusig is making 340B covered entities declare on a form whether they will opt in or opt out of 340B pricing on purchases, as a condition for obtaining Takeda’s drug.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
